Antagonists of the human CCR5 receptor as anti-HIV-1 agents.: Part 3:: A proposed pharmacophore model for 1-[N-(methyl)-N-(phenylsulfonyl)amino]-2-(phenyl)4-[4-(substituted)piperidin-1yl]butanes

被引：44

作者：

Finke, PE

Meurer, LC

Oates, B

Shah, SK

Loebach, JL

Mills, SG

MacCoss, M

Castonguay, L

Malkowitz, L

Springer, MS

Gould, SL

DeMartino, JA

机构：

[1] Merck Res Labs, Dept Med Chem, Rahway, NJ 07065 USA

[2] Merck Res Labs, Dept Mol Syst, Rahway, NJ 07065 USA

[3] Merck Res Labs, Dept Immunol Res, Rahway, NJ 07065 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2001年 / 11卷 / 18期

关键词：

D O I：

10.1016/S0960-894X(01)00491-7

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Structure-activity relationship studies directed toward the optimization of (2S)-2-(3-chlorophenyl)-1-[N-(methyl)-N-(phenylsulfonyl)amino]-4-[-(substituted)piperidin-1-yl]butanes as CCR5 antagonists resulted in the synthesis of the spiro-indanone derivative 8c (IC50 = 5 nM). These and previous results are summarized in a proposed pharmacophore model for this class of CCR5 antagonist. (C) 2001 Elsevier Science Ltd. All rights reserved.

引用

页码：2469 / 2473

页数：5

共 22 条

[1] Reductive amination of aldehydes and ketones with sodium triacetoxyborohydride. Studies on direct and indirect reductive amination procedures
AbdelMagid, AF
Carson, KG
Harris, BD
Maryanoff, CA
Shah, RD
[J]. JOURNAL OF ORGANIC CHEMISTRY, 1996, 61 (11) : 3849 - 3862
[2] ARMOUR DR, 2000, Patent No. 1013276
[3] Human chemokines: An update
Baggiolini, M
Dewald, B
Moser, B
[J]. ANNUAL REVIEW OF IMMUNOLOGY, 1997, 15 : 675 - 705
[4] BAROUDY BM, 2000, Patent No. [066558, 0066558]
[5] HIV-1 entry - an expanding portal for drug discovery
Blair, WS
Lin, PF
Meanwell, NA
Wallace, OB
[J]. DRUG DISCOVERY TODAY, 2000, 5 (05) : 183 - 194
[6] IN-VIVO EMERGENCE OF HIV-1 VARIANTS RESISTANT TO MULTIPLE PROTEASE INHIBITORS
CONDRA, JH
SCHLEIF, WA
BLAHY, OM
GABRYELSKI, LJ
GRAHAM, DJ
QUINTERO, JC
RHODES, A
ROBBINS, HL
ROTH, E
SHIVAPRAKASH, M
TITUS, D
YANG, T
TEPPLER, H
SQUIRES, KE
DEUTSCH, PJ
EMINI, EA
[J]. NATURE, 1995, 374 (6522) : 569 - 571
[7] Antagonists of the human CCR5 receptor as anti-HIV-1 agents. Part 1: Discovery and initial structure-activity relationships for 1-amino-2-phenyl-4-(piperidin-1-yl)butanes
Dorn, CP
Finke, PE
Oates, B
Budhu, RJ
Mills, SG
MacCoss, M
Malkowitz, L
Springer, MS
Daugherty, BL
Gould, SL
DeMartino, JA
Siciliano, SJ
Carella, A
Carver, G
Holmes, K
Danzeisen, R
Hazuda, D
Kessler, J
Lineberger, J
Miller, M
Schleif, WA
Emini, EA
[J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2001, 11 (02) : 259 - 264
[8] ACTION OF METAL HYDRIDES ON BETA-(3-INDOLYL)ETHYL-1-PYRIDINIUM SALTS
ELDERFIELD, RC
FISCHER, B
LAGOWSKI, JM
[J]. JOURNAL OF ORGANIC CHEMISTRY, 1957, 22 (11) : 1376 - 1380
[9] Host factors and the pathogenesis of HIV-induced disease
Fauci, AS
[J]. NATURE, 1996, 384 (6609) : 529 - 534
[10] Antagonists of the human CCR5 receptor as anti-HIV-1 agents.: Part 4:: Synthesis and structure-activity relationships for 1-[N(methyl)-N-(phenylsulfonyl)amino]-2-(phenyl)-4-(4-(N-(alkyl)-N- (benzyloxycarbonyl)amino)piperidin-1-yl)butanes
Finke, PE
Oates, B
Mills, SG
MacCoss, M
Malkowitz, L
Springer, MS
Gould, SL
DeMartino, JA
Carella, A
Carver, G
Holmes, K
Danzeisen, R
Hazuda, D
Kessler, J
Lineberger, J
Miller, M
Schleif, WA
Emini, EA
[J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2001, 11 (18) : 2475 - 2479

← 1 2 3 →